John J. Morton

3.5k total citations
46 papers, 2.0k citations indexed

About

John J. Morton is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John J. Morton has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John J. Morton's work include Heart Failure Treatment and Management (14 papers), Hormonal Regulation and Hypertension (8 papers) and Renin-Angiotensin System Studies (6 papers). John J. Morton is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Hormonal Regulation and Hypertension (8 papers) and Renin-Angiotensin System Studies (6 papers). John J. Morton collaborates with scholars based in United Kingdom, United States and Switzerland. John J. Morton's co-authors include J. I. S. Robertson, John G.F. Cleland, Ian Robertson, B.W. East, Henry J. Dargie, G P Hodsman, Anthony J. Gill, Allan D. Struthers, John H. Morton and John J.V. McMurray and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

John J. Morton

44 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Morton United Kingdom 22 1.5k 364 352 261 246 46 2.0k
C. Dal Palú Italy 19 1.3k 0.9× 302 0.8× 363 1.0× 291 1.1× 107 0.4× 73 1.7k
Fetnat M. Fouad United States 23 1.8k 1.3× 244 0.7× 451 1.3× 670 2.6× 231 0.9× 44 2.4k
M. E. Safar France 23 1.6k 1.1× 328 0.9× 189 0.5× 358 1.4× 112 0.5× 65 2.0k
A Amery Belgium 21 972 0.7× 198 0.5× 314 0.9× 295 1.1× 100 0.4× 112 1.6k
F Burkart Switzerland 26 2.1k 1.4× 337 0.9× 210 0.6× 463 1.8× 245 1.0× 117 2.7k
F H Messerli United States 19 795 0.5× 214 0.6× 249 0.7× 197 0.8× 85 0.3× 49 1.2k
G P Hodsman Australia 19 1.1k 0.8× 294 0.8× 220 0.6× 128 0.5× 286 1.2× 47 1.5k
B. Pitt United States 14 1.4k 1.0× 223 0.6× 607 1.7× 409 1.6× 196 0.8× 41 2.0k
Naoko Mabuchi Japan 16 1.5k 1.0× 194 0.5× 278 0.8× 304 1.2× 326 1.3× 22 2.0k
Dinko Sušić United States 30 1.4k 1.0× 209 0.6× 576 1.6× 355 1.4× 328 1.3× 91 2.2k

Countries citing papers authored by John J. Morton

Since Specialization
Citations

This map shows the geographic impact of John J. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Morton more than expected).

Fields of papers citing papers by John J. Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Morton. The network helps show where John J. Morton may publish in the future.

Co-authorship network of co-authors of John J. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Morton. A scholar is included among the top collaborators of John J. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Morton. John J. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Jihyun, Sean Balmain, Colin Berry, John J. Morton, & John J.V. McMurray. (2010). Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart. 96(7). 533–538. 59 indexed citations
2.
Nielsen, Olav Wendelboe, et al.. (2007). Value of BNP to Estimate Cardiac Risk in Patients on Cardioactive Treatment in Primary Care. European Journal of Heart Failure. 9(12). 1178–1185. 10 indexed citations
3.
Persson, Hans, Eva Lonn, Magnus Edner, et al.. (2007). Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence. Journal of the American College of Cardiology. 49(6). 687–694. 214 indexed citations
4.
Balmain, Sean, Neal Padmanabhan, William R. Ferrell, John J. Morton, & John J.V. McMurray. (2007). Differences in Arterial Compliance, Microvascular Function and Venous Capacitance Between Patients with Heart Failure and Either Preserved or Reduced Left Ventricular Systolic Function. European Journal of Heart Failure. 9(9). 865–871. 64 indexed citations
5.
Robb, Stephen, Theresa A. McDonagh, Michele Robertson, et al.. (2003). N-T Pro-BNP is a powerful predictor of outcome in patients with stable angina: A substudy of the IONA trial. Journal of the American College of Cardiology. 41(6). 360–360.
6.
McDonagh, T., et al.. (2000). N-Terminal Pro BNP and the Prognosis of Left Ventricular Dysfunction in a Population-Based Study. European Journal of Heart Failure. 2(S1). 48–48. 1 indexed citations
7.
Motwani, Joseph G., Michael K. Fenwick, John J. Morton, & Allan D. Struthers. (1994). Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease. The American Journal of Cardiology. 73(16). 1191–1196. 6 indexed citations
8.
Angus, Robert, et al.. (1994). Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function.. Thorax. 49(5). 492–495. 63 indexed citations
9.
Richards, Mark, M. Tree, Giancarlo Tonolo, et al.. (1993). Atrial Natriuretic Factor and Changes in the Aldosterone Response to Angiotensin II in Sodium Depleted Dogs. Clinical and Experimental Hypertension. 15(2). 379–394. 5 indexed citations
10.
Fenwick, Michael K., et al.. (1992). Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.. Circulation. 86(2). 439–445. 35 indexed citations
11.
Richards, Mark, Giancarlo Tonolo, Piero Montorsi, et al.. (1988). Low Dose Infusions of 26- and 28-Amino Acid Human Atrial Natriuretic Peptides in Normal Man*. The Journal of Clinical Endocrinology & Metabolism. 66(3). 465–472. 74 indexed citations
12.
Cleland, John G.F., Henry J. Dargie, Stephen G. Ball, et al.. (1985). Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.. Heart. 54(3). 305–312. 236 indexed citations
13.
Hodsman, G P, J. J. Brown, A. M. M. Cumming, et al.. (1984). Enalapril in the Treatment of Hypertension With Renal Artery Stenosis. The Journal of Urology. 131(5). 1024–1024. 4 indexed citations
14.
Cleland, John G.F., Henry J. Dargie, G P Hodsman, et al.. (1984). Captopril in heart failure. A double blind controlled trial.. Heart. 52(5). 530–535. 309 indexed citations
15.
16.
17.
Rosei, E. Agabiti, R. Fräser, John J. Morton, et al.. (1977). Labetalol, an α- and β-adrenergic blocking drugin the treatment of hypertension. American Heart Journal. 93(1). 124–125. 5 indexed citations
18.
Semple, P F & John J. Morton. (1976). Angiotensin II and angiotensin III in rat blood.. Circulation Research. 38(6). 122–126. 51 indexed citations
19.
Schalekamp, Maarten A.D.H., DG Beevers, J. D. Briggs, et al.. (1973). Hypertension in chronic renal failure. The American Journal of Medicine. 55(3). 379–390. 135 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Dal Palú Breakdown of academic impact, for papers by Fetnat M. Fouad Breakdown of academic impact, for papers by M. E. Safar Breakdown of academic impact, for papers by A Amery Breakdown of academic impact, for papers by F Burkart Breakdown of academic impact, for papers by F H Messerli Breakdown of academic impact, for papers by G P Hodsman Breakdown of academic impact, for papers by B. Pitt Breakdown of academic impact, for papers by Naoko Mabuchi Breakdown of academic impact, for papers by Dinko Sušić
Rankless by CCL
2026